DURECT (NASDAQ:DRRX) Upgraded at StockNews.com

StockNews.com upgraded shares of DURECT (NASDAQ:DRRX – Free Report) from a sell rating to a hold rating in a research note published on Tuesday. A number of other equities research analysts have also recently issued reports on the stock. Cantor Fitzgerald dropped their price target on shares of DURECT from $44.00 to $41.00 and set […]

Leave a Reply

Your email address will not be published.

Previous post Copa (NYSE:CPA) Upgraded at StockNews.com
Next post GitLab (NASDAQ:GTLB) Given New $70.00 Price Target at Royal Bank of Canada